نتایج جستجو برای: آنزیم mva

تعداد نتایج: 13519  

Journal: :Journal of traumatic stress 2008
Goro Fujita Yasushi Nishida

Associations of objective measures of trauma exposure with psychological sequelae following motor vehicle accidents (MVA) were examined in a Japanese population. Impact and injury severity of 93 MVA victims was assessed using on-the-scene in-depth investigations measured by the Injury Severity Score (ISS), barrier equivalent speed (BES), and change in velocity during the impact (Delta-v). Resul...

Journal: :Journal of anxiety disorders 2014
Bryce Hruska Leah A Irish Maria L Pacella Eve M Sledjeski Douglas L Delahanty

We conducted a latent class analysis (LCA) on 249 recent motor vehicle accident (MVA) victims to examine subgroups that differed in posttraumatic stress disorder (PTSD) symptom severity, current major depressive disorder and alcohol/other drug use disorders (MDD/AoDs), gender, and interpersonal trauma history 6-weeks post-MVA. A 4-class model best fit the data with a resilient class displaying ...

2017
Alberto C Guardo Carmen Elena Gómez Vicens Díaz-Brito Judit Pich Joan Albert Arnaiz Beatriz Perdiguero Juan García-Arriaza Nuria González Carlos O S Sorzano Laura Jiménez José Luis Jiménez María Ángeles Muñoz-Fernández José M Gatell José Alcamí Mariano Esteban Juan Carlos López Bernaldo de Quirós Felipe García Montserrat Plana

BACKGROUND We have previously shown that an HIV vaccine regimen including three doses of HIV-modified vaccinia virus Ankara vector expressing HIV-1 antigens from clade B (MVA-B) was safe and elicited moderate and durable (1 year) T-cell and antibody responses in 75% and 95% of HIV-negative volunteers (n = 24), respectively (RISVAC02 study). Here, we describe the long-term durability of vaccine-...

2010
Gaetano Antonio Lanza

Myocardial ischemia is usually caused by abnormalities of epicardial coronary arteries. In the past 30 years, however, several studies have shown that abnormalities in coronary microcirculation may also cause or contribute to myocardial ischemia in several conditions. Accordingly, Camici and Crea1 have recently proposed a classification of coronary microvascular dysfunction (CMVD) based on the ...

Journal: :Journal of virology 2014
Nicholas W Florek Jason T Weinfurter Sinthujan Jegaskanda Joseph N Brewoo Tim D Powell Ginger R Young Subash C Das Masato Hatta Karl W Broman Olav Hungnes Susanne G Dudman Yoshihiro Kawaoka Stephen J Kent Dan T Stinchcomb Jorge E Osorio Thomas C Friedrich

UNLABELLED Current influenza virus vaccines primarily aim to induce neutralizing antibodies (NAbs). Modified vaccinia virus Ankara (MVA) is a safe and well-characterized vector for inducing both antibody and cellular immunity. We evaluated the immunogenicity and protective efficacy of MVA encoding influenza virus hemagglutinin (HA) and/or nucleoprotein (NP) in cynomolgus macaques. Animals were ...

Journal: :فصلنامه علمی پژوهشی گیاهان دارویی 0
a qaderi m omidi a etminan a oladzad c ebrahimi mr dehghani mashkani

taxol is used to treatment of variety cancers including ovarian, breast, lung, head and neck carcinomas and the aids-related karposi’s carcinoma, and was originally obtained from bark of taxus brevifolia. however the amount of extracted taxol from taxus is extremely low and cannot be considered as a suitable commercial source and it has led to studies for finding new sources of taxol. in 1998, ...

2016
Richard N Greenberg Christine M Hay Jack T Stapleton Thomas C Marbury Eva Wagner Eva Kreitmeir Siegfried Röesch Alfred von Krempelhuber Philip Young Richard Nichols Thomas P Meyer Darja Schmidt Josef Weigl Garth Virgin Nathaly Arndtz-Wiedemann Paul Chaplin

BACKGROUND Modified Vaccinia Ankara MVA-BN® is a live, highly attenuated, viral vaccine under advanced development as a non-replicating smallpox vaccine. In this Phase II trial, the safety and immunogenicity of Modified Vaccinia Ankara MVA-BN® (MVA) was assessed in a 56-80 years old population. METHODS MVA with a virus titer of 1 x 108 TCID50/dose was administered via subcutaneous injection t...

Journal: :The Journal of infectious diseases 2009
J H C M Kreijtz Y Suezer G de Mutsert J M A van den Brand G van Amerongen B S Schnierle T Kuiken R A M Fouchier J Löwer A D M E Osterhaus G Sutter G F Rimmelzwaan

BACKGROUND Highly pathogenic avian influenza viruses of the H5N1 subtype have been responsible for an increasing number of infections in humans since 2003. More than 60% of infected individuals die, and new infections are reported frequently. In light of the pandemic threat caused by these events, the rapid availability of safe and effective vaccines is desirable. Modified vaccinia virus Ankara...

Journal: :The Journal of infectious diseases 2010
Marissa B Wilck Michael S Seaman Lindsey R Baden Stephen R Walsh Lauren E Grandpre Colleen Devoy Ayush Giri Jane A Kleinjan Lizanne C Noble Kristen E Stevenson Haesook T Kim Raphael Dolin

BACKGROUND We conducted a clinical trial of the safety and immunogenicity of modified vaccinia Ankara (MVA) to examine the effects of dose and route of administration. METHODS Seventy-two healthy, vaccinia virus-naive subjects received 1 of 6 regimens of MVA (ACAM3000) or placebo consisting of 2 administrations given 1 month apart. RESULTS MVA was generally well tolerated at all dose levels...

2018
Maria Lisa Odland Gladys Membe-Gadama Ursula Kafulafula Geir W Jacobsen James Kumwenda Elisabeth Darj

Malawi has a high maternal mortality rate, of which unsafe abortion is a major cause. About 140,000 induced abortions are estimated every year, despite there being a restrictive abortion law in place. This leads to complications, such as incomplete abortions, which need to be treated to avoid further harm. Although manual vacuum aspiration (MVA) is a safe and cheap method of evacuating the uter...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید